Bristol-Myers Squibb Company's Ex R&D Chief Talks About Life After Big Pharma
Published: Feb 25, 2014
Less than a year ago, Elliott Sigal, Bristol-Myers Squibb’s R&D chief for nearly a decade, stunned the industry. After a lengthy run that saw Bristol morph from a slogging, multifaceted healthcare conglomerate with its fingers in everything from AIDS drugs to baby formula, to a sleeker, pure play biopharmaceutical company, Sigal abruptly walked away in April 2013. “I envision an active retirement,” he said on a conference call with investors at the time.
Help employers find you! Check out all the jobs and post your resume.